Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.39
Delayed Data
As of Apr 26
 -0.12 / -1.60%
Today’s Change
6.15
Today|||52-Week Range
11.34
-17.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.00641.0K2.5M
 
 
 
Cost of Goods Sold0.000.00486.0K182.0K
 
 
 
Depreciation And Amortization6.0K4.0K4.0K5.0K
 
 
 
 
 
 
Operating ExpensesGross Income-6.0K-4.0K151.0K2.3M
 
 
 
 
 
General Expenses6.3M7.4M10.2M13.0M
 
 
 
 
 
Research And Development3.7M4.8M7.7M10.3M
 
 
 
 
 
Total Operating Expenses6.3M7.4M10.7M13.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.3M-7.4M-10.0M-10.8M
 
 
 
 
 
Interest Expense On Debt0.009.0K11.0K6.0K
 
 
 
 
Other Expenses504.0K40.0K-82.0K-88.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-7.2M-9.6M-10.1M
 
 
 
 
 
Income Taxes-4.0K-1.0K-1.3M-400.0K
 
 
 
 
 
Net Income-5.7M-7.2M-11.0M-10.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.2M10.8M12.6M13.3M
 
 
 
 
 
Shares To Calculate EPS Diluted9.2M10.8M12.6M13.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.62-$0.67-$0.87-$0.79
 
 
 
 
 
EPS Diluted-$0.62-$0.67-$0.87-$0.79